Trial · NCT00884741
Participant flow36
How many started, completed or left each group, period by period.
1 to 20 of 36
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Step 1 Registration: Tissue Screening | STARTED | Step 1 Registration | 978 | |
| Step 1 Registration: Tissue Screening | STARTED | Step 2 Registration: Pre-Randomization TMZ+RT | 0 | |
| Step 1 Registration: Tissue Screening | STARTED | Randomized Arm 1: TMZ+RT + Placebo | 0 | |
| Step 1 Registration: Tissue Screening | STARTED | Randomized Arm 2: TMZ+RT + Bevacizumab | 0 | |
| Step 1 Registration: Tissue Screening | COMPLETED | Step 1 Registration | 666 | |
| Step 1 Registration: Tissue Screening | COMPLETED | Step 2 Registration: Pre-Randomization TMZ+RT | 0 | |
| Step 1 Registration: Tissue Screening | COMPLETED | Randomized Arm 1: TMZ+RT + Placebo | 0 | |
| Step 1 Registration: Tissue Screening | COMPLETED | Randomized Arm 2: TMZ+RT + Bevacizumab | 0 | |
| Step 1 Registration: Tissue Screening | NOT COMPLETED | Step 1 Registration | 312 | |
| Step 1 Registration: Tissue Screening | NOT COMPLETED | Step 2 Registration: Pre-Randomization TMZ+RT | 0 | |
| Step 1 Registration: Tissue Screening | NOT COMPLETED | Randomized Arm 1: TMZ+RT + Placebo | 0 | |
| Step 1 Registration: Tissue Screening | NOT COMPLETED | Randomized Arm 2: TMZ+RT + Bevacizumab | 0 | |
| Step 2 Registration: Tissue Analysis | STARTED | Step 1 Registration | 0 | |
| Step 2 Registration: Tissue Analysis | STARTED | Step 2 Registration: Pre-Randomization TMZ+RT | 666 | |
| Step 2 Registration: Tissue Analysis | STARTED | Randomized Arm 1: TMZ+RT + Placebo | 0 | |
| Step 2 Registration: Tissue Analysis | STARTED | Randomized Arm 2: TMZ+RT + Bevacizumab | 0 | |
| Step 2 Registration: Tissue Analysis | COMPLETED | Step 1 Registration | 0 | |
| Step 2 Registration: Tissue Analysis | COMPLETED | Step 2 Registration: Pre-Randomization TMZ+RT | 637 | |
| Step 2 Registration: Tissue Analysis | COMPLETED | Randomized Arm 1: TMZ+RT + Placebo | 0 | |
| Step 2 Registration: Tissue Analysis | COMPLETED | Randomized Arm 2: TMZ+RT + Bevacizumab | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00884741/flow